PlainPharmaWatch

CMS Open Payments · Tool

Arthrex, Inc. vs Edge Endo LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Edge Endo LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,988, versus 439 for the other company. Its single largest recorded recipient represents 99.9% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Arthrex, Inc.
HHI 439 · top recipient 16.6%
Ranked #1,342 of 1,838 companies by HHI
Edge Endo LLC
HHI 9,988 · top recipient 99.9%
Ranked #132 of 1,838 companies by HHI

Payment Overview

Company A

Arthrex, Inc.

Total Payments
$109.0M
% of Industry
0.8%
Transactions
50,254
Avg per Transaction
$2.2K
Recipients
49,842
Avg per Recipient
$2.2K
Payment Types
9
Top Payment Type
Royalty or License
Company B

Edge Endo LLC

Total Payments
$113.4M
% of Industry
0.8%
Transactions
41
Avg per Transaction
$2.8M
Recipients
40
Avg per Recipient
$2.8M
Payment Types
3
Top Payment Type
Acquisitions

Highlighted values indicate the higher figure for each metric.

Total payments compared

Arthrex, Inc. vs Edge Endo LLC - total reported payments in CMS Open Payments PY2024

Edge Endo LLC$113.4MArthrex, Inc.$109.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Arthrex, Inc.

Royalty or License $82.2M

78.8%

Compensation for Services Other Than Consulting $10.7M

10.2%

Consulting Fee $3.9M

3.7%

Grant $3.3M

3.2%

Travel and Lodging $3.3M

3.2%

Food and Beverage $886.3K

0.8%

Edge Endo LLC

Acquisitions $91.1M

99.9%

Consulting Fee $45.5K

0.0%

Long-Term Medical Supply or Device Loan $10.9K

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Arthrex, Inc.

  1. 1

    STEPHEN BURKHART

    $17,332,176.23 · 3 txns

  2. 2

    NEAL ELATTRACHE

    $6,849,196.56 · 20 txns

  3. 3

    ANTHONY ROMEO

    $4,845,177.11 · 107 txns

  4. 4

    PAUL BRADY

    $4,589,730.35 · 98 txns

  5. 5

    BENJAMIN DOMB

    $3,324,603.65 · 58 txns

Edge Endo LLC

  1. 1

    CHARLES GOODIS

    $91,082,706.03 · 1 txns

  2. 2

    JUSTIN KOLNICK

    $28,550.87 · 19 txns

  3. 3

    CHARLES MAUPIN

    $11,042.88 · 13 txns

  4. 4

    GEORGE GOODIS

    $7,327.09 · 1 txns

  5. 5

    FREDERIC BARNETT

    $4,000.00 · 2 txns

Summary Comparison

Metric Arthrex, Inc. Edge Endo LLC
Total Payments $109.0M $113.4M
% of Industry Total 0.8% 0.8%
Transaction Count 50,254 41
Avg per Transaction $2.2K $2.8M
Recipient Count 49,842 40
Avg per Recipient $2.2K $2.8M
Payment Type Count 9 3
Top Payment Type Royalty or License Acquisitions

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.